← Leaderboards
Robert Henry Roth
Yale University
$12,108,184
Attributed
$13,381,770
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$13,381,770 · 6
By mechanism
R01$11,567,553 · 4
P01$1,471,038 · 1
R37$343,179 · 1
Top collaborators
- John D Elsworth4 shared
Most similar at Yale University
Same institution · by research overlap
- Shuta Ishibe$11,492,076
- Steven G Coca$6,183,329
- Stefan Somlo$20,826,249
- Robert Stanley Sherwin$134,887,212
- Lloyd G Cantley$26,240,423
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineAntipsychotic AgentsPhencyclidineNeurochemistryPrimatesClozapineDopamine ReceptorPrefrontal Lobe /CortexSchizophreniaLaboratory RatNeuronsBehavioralHigh Performance Liquid ChromatographyMonkeysInsightPrefrontal CortexMediatingNeurobiologyNeurotransmitter MetabolismImpaired CognitionPharmaceutical PreparationsDesignCognitiveAtypical Antipsychotic
Grant awards (33)
Biochemical and Synaptic Mechanisms in Prefrontal Cortex and Vulnerability for Cognitive Deficits$622,532
R01 · FY2019 · MH
Biochemical and Synaptic Mechanisms in Prefrontal Cortex and Vulnerability for Cognitive Deficits$622,532
R01 · FY2018 · MH
Biochemical and Synaptic Mechanisms in Prefrontal Cortex and Vulnerability for Cognitive Deficits$621,844
R01 · FY2017 · MH
Biochemical and Synaptic Mechanisms in Prefrontal Cortex and Vulnerability for Cognitive Deficits$680,264
R01 · FY2016 · MH
Chronic PCP Primate PFC Dopamine Deficit and Schizophrenia$525,284
R01 · FY2011 · MH · contact PI
Chronic PCP Primate PFC Dopamine Deficit and Schizophrenia$515,137
R01 · FY2010 · MH · contact PI
Chronic PCP Primate PFC Dopamine Deficit and Schizophrenia$854,129
R01 · FY2009 · MH · contact PI
Chronic PCP Primate PFC Dopamine Deficit and Schizophrenia$507,749
R01 · FY2009 · MH · contact PI
Chronic PCP Primate PFC Dopamine Deficit and Schizophrenia$492,712
R01 · FY2008 · MH · contact PI
Chronic PCP Primate PFC Dopamine Deficit and Schizophrenia$491,408
R01 · FY2007 · MH · contact PI
Enhancing function of grafted primate dopamine neurons with neurotrophic factors$279,656
P01 · FY2007 · NS · contact PI
Antipsychotic Drugs and Control of Dopaminergic Neurons$398,859
R01 · FY2006 · MH · contact PI
Enhancing function of grafted primate dopamine neurons$294,939
P01 · FY2006 · NS · contact PI
Prenatal Cocaine Alters Cortical Dopamine Function$279,402
R01 · FY2006 · DA · contact PI
DOPAMINE DEFICIT AND SCHIZOPHRENIA$410,346
R01 · FY2005 · MH
Antipsychotic Drugs and Control of Dopaminergic Neurons$408,458
R01 · FY2005 · MH
Enhancing function of grafted primate dopamine neurons$294,939
P01 · FY2005 · NS
Prenatal Cocaine Alters Cortical Dopamine Function$286,125
R01 · FY2005 · DA
Antipsychotic Drugs and Control of Dopaminergic Neurons$408,458
R01 · FY2004 · MH
DOPAMINE DEFICIT AND SCHIZOPHRENIA$398,392
R01 · FY2004 · MH
Enhancing function of grafted primate dopamine neurons$294,939
P01 · FY2004 · NS
Prenatal Cocaine Alters Cortical Dopamine Function$286,125
R01 · FY2004 · DA
Antipsychotic Drugs and Control of Dopaminergic Neurons$416,241
R01 · FY2003 · MH
DOPAMINE DEFICIT AND SCHIZOPHRENIA$386,788
R01 · FY2003 · MH
Enhancing function of grafted primate dopamine neurons$306,565
P01 · FY2003 · NS
Prenatal Cocaine Alters Cortical Dopamine Function$286,125
R01 · FY2003 · DA
Antipsychotic Drugs and Control of Dopaminergic Neurons$408,458
R01 · FY2002 · MH
DOPAMINE DEFICIT AND SCHIZOPHRENIA$375,521
R01 · FY2002 · MH
Prenatal Cocaine Alters Cortical Dopamine Function$286,125
R01 · FY2002 · DA
Antipsychotic Drugs and Control of Dopaminergic Neurons$5,363
R01 · FY2002 · MH
DOPAMINE DEFICIT AND SCHIZOPHRENIA$382,572
R01 · FY2001 · MH
ANTIPSYCHOTIC DRUGS AND CONTROL OF DOPAMINERGIC NEURONS$343,179
R37 · FY2000 · MH
PRENATAL COCAINE ALTERS CORTICAL DOPAMINE FUNCTION$210,604
R01 · FY2000 · DA